UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A case-control study of perfluoroalkyl substances and the risk of breast cancer in Taiwanese women

Environment international, 2020-09, Vol.142, p.105850, Article 105850

2020

Volltextzugriff (PDF)

Role of Alpelisib in the Treatment of PIK3CA-Mutated Breast Cancer: Patient Selection and Clinical Perspectives

Therapeutics and clinical risk management, 2021-01, Vol.17, p.193-207

2021

Volltextzugriff (PDF)

Disparity in survival benefits of pembrolizumab between Asian and non‐Asian patients with advanced cancers: A systematic review and meta‐regression analysis

Cancer medicine (Malden, MA), 2023-10, Vol.12 (19), p.20035-20051

2023

Volltextzugriff (PDF)

Anti-HER2 antibody prolongs overall survival disproportionally more than progression-free survival in HER2-Positive metastatic breast cancer patients

Breast (Edinburgh), 2021-10, Vol.59, p.211-220

2021

Volltextzugriff (PDF)

Concurrent epirubicin and trastuzumab use increases complete pathological response rate without additional cardiotoxicity in patients with human epidermal growth factor receptor 2‐positive early breast cancer: A meta‐regression analysis

Cancer medicine (Malden, MA), 2024-07, Vol.13 (14), p.e70005-n/a

2024

Volltextzugriff (PDF)

TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays

Scientific reports, 2015-12, Vol.5 (1), p.17879-17879, Article 17879

2015

Volltextzugriff (PDF)

A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer

Japanese journal of clinical oncology, 2018-03, Vol.48 (3), p.242-247

2018

Volltextzugriff (PDF)

High Prevalence of the BIM Deletion Polymorphism in Young Female Breast Cancer in an East Asian Country

PloS one, 2015-04, Vol.10 (4), p.e0124908

2015

Volltextzugriff (PDF)

Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer

Breast cancer research and treatment, 2023-10, Vol.201 (3), p.377-385

2023

Volltextzugriff (PDF)

Clinical Outcomes of Metastatic Breast Cancer in Patients Having Imaging Liver Pseudocirrhosis with or without Evident Varices

The oncologist (Dayton, Ohio), 2022-12, Vol.27 (12), p.1008-1015

2022

Volltextzugriff (PDF)

Factors Impacting Prognosis Prediction in BCLC Stage C and Child‐Pugh Class A Hepatocellular Carcinoma Patients in Prospective Clinical Trials of Systemic Therapy

The oncologist (Dayton, Ohio), 2012-07, Vol.17 (7), p.970-977

2012

Volltextzugriff (PDF)

Acute Hyponatremia Complicated with Seizure after Adjuvant Chemotherapy with Cyclophosphamide and Epirubicin in a Breast Cancer Patient

Journal of cancer research and practice, 2015-06, Vol.2 (2), p.157-161

2015

Volltextzugriff (PDF)

Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer: A Randomized Clinical Trial

JAMA oncology, 2024-03, Vol.10 (3), p.325

2024

Volltextzugriff (PDF)

Malignant Pleural Mesothelioma with Extensive Skeletal Muscle Metastasis

Journal of cancer research and practice, 2014-09, Vol.1 (2), p.134-139

2014

Volltextzugriff (PDF)

Vitiligo after immune checkpoint inhibitor therapy in a woman with metastatic melanoma

Journal of cancer research and practice, 2018-12, Vol.5 (4), p.161-164

2018

Volltextzugriff (PDF)

Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation

Journal of clinical pathology, 2013-02, Vol.66 (2), p.140-145

2013

Volltextzugriff (PDF)

Locoregional therapy improves survival for metastatic breast cancer patients? Benefit remains questionable

Journal of clinical oncology, 2009-11, Vol.27 (31), p.e179; author reply e180-e179

2009

Volltextzugriff (PDF)

The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: A comparative study of the efficacy of anthracyclines and non-anthracyclines

Breast (Edinburgh), 2013-12, Vol.22 (6), p.1148-1154

2013

Volltextzugriff (PDF)

Prognostic molecular markers in women aged 35 years or younger with breast cancer: is there a difference from the older patients?

Journal of clinical pathology, 2011-09, Vol.64 (9), p.781-787

2011

Volltextzugriff (PDF)

Vinorelbine plus 24-Hour Infusion of High-dose 5-Fluorouracil and Leucovorin as Effective Palliative Chemotherapy for Breast Cancer Patients with Acute Disseminated Intravascular Coagulation

Anticancer research, 2010-07, Vol.30 (7), p.3087-3091

2010

Volltextzugriff (PDF)

A meta-analysis of cardiac toxicity of concurrent epirubicin and trastuzumab in early breast cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e12583-e12583

2023

Volltextzugriff (PDF)

Different efficacy of pembrolizumab in overall survival between Asians and non-Asians with advanced cancers: A systematic review and meta-regression analysis

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e13597-e13597

2023

Volltextzugriff (PDF)

ORACLE-RIPA study: A phase II, randomized, open-label, parallel-group study comparing the immune modulation effect of neoadjuvant ribociclib, palbociclib, and abemaciclib in early ER+/HER2- breast cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS632-TPS632

2023

Volltextzugriff (PDF)

Abstract CT028: A pilot study of pembrolizumab and exemestane/leuprolide in premenopausal hormone receptor positive/HER2 negative locally advanced or metastatic breast cancer (PEER)

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.CT028-CT028

2021

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(32)

Sprache

Englisch
(31)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A case-control study of perfluoroalkyl substances and the risk of breast cancer in Taiwanese women

Role of Alpelisib in the Treatment of PIK3CA-Mutated Breast Cancer: Patient Selection and Clinical Perspectives

Disparity in survival benefits of pembrolizumab between Asian and non‐Asian patients with advanced cancers: A systematic review and meta‐regression analysis

Anti-HER2 antibody prolongs overall survival disproportionally more than progression-free survival in HER2-Positive metastatic breast cancer patients

Concurrent epirubicin and trastuzumab use increases complete pathological response rate without additional cardiotoxicity in patients with human epidermal growth factor receptor 2‐positive early breast cancer: A meta‐regression analysis

TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays

A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer

High Prevalence of the BIM Deletion Polymorphism in Young Female Breast Cancer in an East Asian Country

Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer

Clinical Outcomes of Metastatic Breast Cancer in Patients Having Imaging Liver Pseudocirrhosis with or without Evident Varices

Factors Impacting Prognosis Prediction in BCLC Stage C and Child‐Pugh Class A Hepatocellular Carcinoma Patients in Prospective Clinical Trials of Systemic Therapy

Acute Hyponatremia Complicated with Seizure after Adjuvant Chemotherapy with Cyclophosphamide and Epirubicin in a Breast Cancer Patient

Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer: A Randomized Clinical Trial

Malignant Pleural Mesothelioma with Extensive Skeletal Muscle Metastasis

Vitiligo after immune checkpoint inhibitor therapy in a woman with metastatic melanoma

A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer

Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation

Locoregional therapy improves survival for metastatic breast cancer patients? Benefit remains questionable

The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: A comparative study of the efficacy of anthracyclines and non-anthracyclines

Prognostic molecular markers in women aged 35 years or younger with breast cancer: is there a difference from the older patients?

Vinorelbine plus 24-Hour Infusion of High-dose 5-Fluorouracil and Leucovorin as Effective Palliative Chemotherapy for Breast Cancer Patients with Acute Disseminated Intravascular Coagulation

A meta-analysis of cardiac toxicity of concurrent epirubicin and trastuzumab in early breast cancer

Different efficacy of pembrolizumab in overall survival between Asians and non-Asians with advanced cancers: A systematic review and meta-regression analysis

ORACLE-RIPA study: A phase II, randomized, open-label, parallel-group study comparing the immune modulation effect of neoadjuvant ribociclib, palbociclib, and abemaciclib in early ER+/HER2- breast cancer

Abstract CT028: A pilot study of pembrolizumab and exemestane/leuprolide in premenopausal hormone receptor positive/HER2 negative locally advanced or metastatic breast cancer (PEER)

Suchergebnisse filtern